Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
Hasnat Tariq,Sannia Batool,Saaim Asif,Mohammad Ali,Bilal Haider Abbasi +4 more
TL;DR: The potential of VLP-based vaccine as viable and efficient immunizing agents to induce immunity against virulent infectious agents, including, SARS-CoV-2 and protein nanoparticle-based vaccines has been elaborated and may serve as an effective alternative to conventional vaccine strategies in combating emerging infectious diseases.
142
Virus-like particle vaccinology, from bench to bedside
TL;DR: A review of the use of VLPs for the development of vaccines with broad fields of indications ranging from classical vaccines against viruses to therapeutic vaccines against chronic inflammation, pain, allergy and cancer can be found in this paper .
Establishing a high yielding streptomyces-based cell-free protein synthesis system.
TL;DR: It is shown that the optimized Streptomyces lividans system provides benefits when compared to an Escherichia coli‐based CFPS system for increasing percent soluble protein expression for four StrePTomyces‐originated high GC‐content genes that are involved in biosynthesis of the nonribosomal peptides tambromycin and valinomycin.
129
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
TL;DR: This review elaborate on the classification, mechanism, and clinical effects of HPV vaccines for disease prevention and treatment, in order to make improvements to the current situation of HPV vaccine by provoking new ideas.
Hepatitis B virus: Where do we stand and what is the next step for eradication?
TL;DR: To eradicate HBV infections, strenuous efforts are required to overcome socioeconomic barriers to the HB vaccine; this task is expected to take several decades to complete.
79